183 related articles for article (PubMed ID: 33008362)
1. Australasian interstitial lung disease registry (AILDR): objectives, design and rationale of a bi-national prospective database.
Moore I; Wrobel J; Rhodes J; Lin Q; Webster S; Jo H; Troy L; Grainge C; Glaspole I; Corte TJ;
BMC Pulm Med; 2020 Oct; 20(1):257. PubMed ID: 33008362
[TBL] [Abstract][Full Text] [Related]
2. Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.
Fisher JH; Kolb M; Algamdi M; Morisset J; Johannson KA; Shapera S; Wilcox P; To T; Sadatsafavi M; Manganas H; Khalil N; Hambly N; Halayko AJ; Gershon AS; Fell CD; Cox G; Ryerson CJ
BMC Pulm Med; 2019 Nov; 19(1):223. PubMed ID: 31771541
[TBL] [Abstract][Full Text] [Related]
3. Interstitial pneumonia with autoimmune features show better survival and less exacerbations compared to idiopathic pulmonary fibrosis.
Lim JU; Gil BM; Kang HS; Oh J; Kim YH; Kwon SS
BMC Pulm Med; 2019 Jul; 19(1):120. PubMed ID: 31272428
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
[TBL] [Abstract][Full Text] [Related]
5. Predicting survival across chronic interstitial lung disease: the ILD-GAP model.
Ryerson CJ; Vittinghoff E; Ley B; Lee JS; Mooney JJ; Jones KD; Elicker BM; Wolters PJ; Koth LL; King TE; Collard HR
Chest; 2014 Apr; 145(4):723-728. PubMed ID: 24114524
[TBL] [Abstract][Full Text] [Related]
6. Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases: Rationale, Aims, and Design of a Nationwide Prospective Registry--The EXCITING-ILD Registry.
Kreuter M; Herth FJ; Wacker M; Leidl R; Hellmann A; Pfeifer M; Behr J; Witt S; Kauschka D; Mall M; Günther A; Markart P
Biomed Res Int; 2015; 2015():123876. PubMed ID: 26640781
[TBL] [Abstract][Full Text] [Related]
7. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Wells AU; Flaherty KR; Brown KK; Inoue Y; Devaraj A; Richeldi L; Moua T; Crestani B; Wuyts WA; Stowasser S; Quaresma M; Goeldner RG; Schlenker-Herceg R; Kolb M;
Lancet Respir Med; 2020 May; 8(5):453-460. PubMed ID: 32145830
[TBL] [Abstract][Full Text] [Related]
8. Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trial.
Saunders P; Tsipouri V; Keir GJ; Ashby D; Flather MD; Parfrey H; Babalis D; Renzoni EA; Denton CP; Wells AU; Maher TM
Trials; 2017 Jun; 18(1):275. PubMed ID: 28619061
[TBL] [Abstract][Full Text] [Related]
9. National Registry of Interstitial Lung Disease from Pakistan.
Zubairi ABS; Ansarie M; Mahmud T; Ashraf S; Rao NA; Javaid A; Shaheen Z; Khan S; Khan A
Cureus; 2021 Apr; 13(4):e14684. PubMed ID: 34055529
[TBL] [Abstract][Full Text] [Related]
10. Cough-Specific Quality of Life Predicts Disease Progression Among Patients With Interstitial Lung Disease: Data From the Pulmonary Fibrosis Foundation Patient Registry.
Lee J; White E; Freiheit E; Scholand MB; Strek ME; Podolanczuk AJ; Patel NM;
Chest; 2022 Sep; 162(3):603-613. PubMed ID: 35337809
[TBL] [Abstract][Full Text] [Related]
11. Nutritional status and quality of life in interstitial lung disease: a prospective cohort study.
Kanjrawi AA; Mathers L; Webster S; Corte TJ; Carey S
BMC Pulm Med; 2021 Feb; 21(1):51. PubMed ID: 33546667
[TBL] [Abstract][Full Text] [Related]
12. Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and Australasia.
Assayag D; Adegunsoye A; Sheehy R; Morisset J; Khalil N; Johannson KA; Marcoux V; Kolb M; Fisher JH; Manganas H; Wrobel J; Wilsher M; De Boer S; Mackintosh J; Chambers DC; Glaspole I; Keir GJ; Lee CT; Jablonski R; Vij R; Strek ME; Corte TJ; Ryerson CJ
Chest; 2023 May; 163(5):1156-1165. PubMed ID: 36621759
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and management of connective tissue disease-associated interstitial lung disease in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand.
Jee AS; Sheehy R; Hopkins P; Corte TJ; Grainge C; Troy LK; Symons K; Spencer LM; Reynolds PN; Chapman S; de Boer S; Reddy T; Holland AE; Chambers DC; Glaspole IN; Jo HE; Bleasel JF; Wrobel JP; Dowman L; Parker MJS; Wilsher ML; Goh NSL; Moodley Y; Keir GJ
Respirology; 2021 Jan; 26(1):23-51. PubMed ID: 33233015
[TBL] [Abstract][Full Text] [Related]
14. The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis Registry.
Ryerson CJ; Tan B; Fell CD; Manganas H; Shapera S; Mittoo S; Sadatsafavi M; To T; Gershon A; Fisher JH; Johannson KA; Hambly N; Khalil N; Marras TK; Morisset J; Wilcox PG; Halayko AJ; Khan MA; Kolb M
Can Respir J; 2016; 2016():3562923. PubMed ID: 27445528
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
[TBL] [Abstract][Full Text] [Related]
16. Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis.
Lee CT; Strek ME; Adegunsoye A; Wong AW; Assayag D; Cox G; Fell CD; Fisher JH; Gershon AS; Halayko AJ; Hambly N; Khalil N; Kolb M; Lok SD; Manganas H; Marcoux V; Morisset J; Sadatsafavi M; Shapera S; To T; Wilcox P; Ryerson CJ; Johannson KA
Respirology; 2022 Aug; 27(8):635-644. PubMed ID: 35512793
[TBL] [Abstract][Full Text] [Related]
17. Demographic and clinical predictors of progression and mortality in connective tissue disease-associated interstitial lung disease: a retrospective cohort study.
Chan C; Ryerson CJ; Dunne JV; Wilcox PG
BMC Pulm Med; 2019 Oct; 19(1):192. PubMed ID: 31672127
[TBL] [Abstract][Full Text] [Related]
18. The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.
Tanizawa K; Handa T; Nakashima R; Kubo T; Hosono Y; Watanabe K; Aihara K; Ikezoe K; Sokai A; Nakatsuka Y; Taguchi Y; Hatta K; Noma S; Kobashi Y; Yoshizawa A; Oga T; Hirai T; Chin K; Nagai S; Izumi T; Mimori T; Mishima M
Respir Med; 2017 Jun; 127():57-64. PubMed ID: 28461123
[TBL] [Abstract][Full Text] [Related]
19. Interstitial Lung Disease in India. Results of a Prospective Registry.
Singh S; Collins BF; Sharma BB; Joshi JM; Talwar D; Katiyar S; Singh N; Ho L; Samaria JK; Bhattacharya P; Gupta R; Chaudhari S; Singh T; Moond V; Pipavath S; Ahuja J; Chetambath R; Ghoshal AG; Jain NK; Devi HJ; Kant S; Koul P; Dhar R; Swarnakar R; Sharma SK; Roy DJ; Sarmah KR; Jankharia B; Schmidt R; Katiyar SK; Jindal A; Mangal DK; Singh V; Raghu G
Am J Respir Crit Care Med; 2017 Mar; 195(6):801-813. PubMed ID: 27684041
[TBL] [Abstract][Full Text] [Related]
20. Interstitial Lung Disease Associated with Connective Tissue Diseases.
Peredo RA; Mehta V; Beegle S
Adv Exp Med Biol; 2021; 1304():73-94. PubMed ID: 34019264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
